Literature DB >> 28865981

Randomized clinical trial of negative pressure wound therapy for high-risk groin wounds in lower extremity revascularization.

Kevin Lee1, Patrick B Murphy2, Matthew V Ingves2, Audra Duncan1, Guy DeRose1, Luc Dubois1, Thomas L Forbes3, Adam Power4.   

Abstract

OBJECTIVE: The surgical site infection (SSI) rate in vascular surgery after groin incision for lower extremity revascularization can lead to significant morbidity and mortality. This trial was designed to study the effect of negative pressure wound therapy (NPWT) on SSI in closed groin wounds after lower extremity revascularization in patients at high risk for SSI.
METHODS: A single-center, randomized, controlled trial was performed at an academic tertiary medical center. Patients with previous femoral artery surgical exposure, body mass index of >30 kg/m2 or the presence of ischemic tissue loss were classified as a high-risk patient for SSI. All wounds were closed primarily and patients were randomized to either NPWT or standard dressing. The primary outcome of the trial was postoperative 30-day SSI in the groin wound. The secondary outcomes included 90-day SSI, hospital duration of stay, readmissions or reoperations for SSI, and mortality.
RESULTS: A total of 102 patients were randomized between August 2014 and December 2015. Patients were classified as at high risk owing to the presence of previous femoral artery cut down (29%), body mass index of >30 kg/m2 (39%) or presence of ischemic tissue loss (32%). Revascularization procedures performed included femoral to distal artery bypass (57%), femoral endarterectomy (18%), femoral to femoral artery crossover (17%), and other procedures (8%). The primary outcome of 30-day SSI was 11% in NPWT group versus 19% in standard dressing group (P = .24). There was a statistically significant shorter mean duration of hospital stay in the NPWT group (6.4 days) compared with the standard group (8.9 days; P = .01). There was no difference in readmission or reoperation for SSI or mortality between the two groups.
CONCLUSIONS: This study demonstrated a nonsignificant lower rate of groin SSI in high-risk revascularization patients with NPWT compared with standard dressing. Owing to a lower than expected infection rate, the study was underpowered to detect a difference at the prespecified level. The NPWT group did show significantly shorter mean hospital duration of stay compared with the standard dressing group.
Copyright © 2017 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28865981     DOI: 10.1016/j.jvs.2017.06.084

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  9 in total

1.  Outcomes of incisional negative pressure wound therapy following brachiobasilic transposition arteriovenous fistula creation: A 1:2 propensity score matched study.

Authors:  Kai Siang Chan; Muthaiah Arunaachalam; Qiantai Hong; En Ming Yong; Pravin Lingam; Li Zhang; Sadhana Chandrasekar; Glenn Wei Leong Tan; Zhiwen Joseph Lo
Journal:  Int Wound J       Date:  2020-04-29       Impact factor: 3.315

Review 2.  Negative pressure wound therapy for surgical wounds healing by primary closure.

Authors:  Gill Norman; Chunhu Shi; En Lin Goh; Elizabeth Ma Murphy; Adam Reid; Laura Chiverton; Monica Stankiewicz; Jo C Dumville
Journal:  Cochrane Database Syst Rev       Date:  2022-04-26

3.  Negative pressure wound therapy for surgical wounds healing by primary closure.

Authors:  Joan Webster; Zhenmi Liu; Gill Norman; Jo C Dumville; Laura Chiverton; Paul Scuffham; Monica Stankiewicz; Wendy P Chaboyer
Journal:  Cochrane Database Syst Rev       Date:  2019-03-26

4.  Negative pressure wound therapy for surgical wounds healing by primary closure.

Authors:  Gill Norman; En Lin Goh; Jo C Dumville; Chunhu Shi; Zhenmi Liu; Laura Chiverton; Monica Stankiewicz; Adam Reid
Journal:  Cochrane Database Syst Rev       Date:  2020-05-01

5.  The Impact of Closed Incision Negative Pressure Therapy on Postoperative Breast Reconstruction Outcomes.

Authors:  Allen Gabriel; Steven Sigalove; Noemi Sigalove; Toni Storm-Dickerson; Jami Rice; Patrick Maxwell; Leah Griffin
Journal:  Plast Reconstr Surg Glob Open       Date:  2018-08-07

Review 6.  Closed Incision Negative Pressure Therapy: Review of the Literature.

Authors:  Luis G Fernandez; Marc R Matthews; Pablo Sibaja Alvarez; Scott Norwood; David H Villarreal
Journal:  Cureus       Date:  2019-07-21

7.  Negative pressure wound therapy (NPWT) on closed incisions to prevent surgical site infection in high-risk patients in hepatopancreatobiliary surgery: study protocol for a randomized controlled trial-the NP-SSI trial.

Authors:  Frank W Brennfleck; Lena Linsenmeier; Henrik H G Junger; Katharina M Schmidt; Jens M Werner; Daniel Woehl; Florian Zeman; Ingrid Mutzbauer; James A Hutchinson; Edward K Geissler; Hans J Schlitt; Stefan M Brunner
Journal:  Trials       Date:  2020-11-09       Impact factor: 2.279

8.  Negative pressure wound therapy for surgical wounds healing by primary closure.

Authors:  Gill Norman; En Lin Goh; Jo C Dumville; Chunhu Shi; Zhenmi Liu; Laura Chiverton; Monica Stankiewicz; Adam Reid
Journal:  Cochrane Database Syst Rev       Date:  2020-06-15

9.  Meta-analysis Comparing Outcomes of Two Different Negative Pressure Therapy Systems in Closed Incision Management.

Authors:  Devinder P Singh; Allen Gabriel; Ronald P Silverman; Leah P Griffin; Lucy D'Agostino McGowan; Ralph B D'Agostino
Journal:  Plast Reconstr Surg Glob Open       Date:  2019-06-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.